In SilicoPrediction of Blood–Brain Partitioning Using a Chemometric Method Called Genetic Algorithm Based Variable Selection

A chemometric method called Genetic Algorithm Based Variable Selection (GAVS) was developed for Quantitative Structure–Property Relationship (QSPR) study here. Different from other GA based techniques, improvements have been made in GAVS, including fitness function and the strategy of elite warehouse. In the case of modeling the Blood–Brain Barrier (BBB) penetration, GAVS performed very well in variable selection. The training set consists of 151 structurally diverse compounds 154 molecular descriptors of which were calculated by E-Dragon. The best model generated by GAVS contained six descriptors with r=0.848, q=0.817, F=61.40. The model was further validated by two external test sets, with the predicted correlation coefficient of 0.837 for Test set I which contained 28 compounds and correct rate of 82.42% for Test set II which included 91 drugs or drug-like compounds with known BBB indication. To the CNS library containing 1283 CNS activities, the model performed with a success rate of 97.3% in predicting CNS active compounds. In comparison with other methods, GAVS performed best among Genetic Function Approximate (GFA) method and other published models. The established predictive model could be applied in design of combinatorial libraries or virtual screening against Central Nervous System (CNS) targets.

[1]  Maxime Culot,et al.  Modelling of the blood–brain barrier in drug discovery and development , 2007, Nature Reviews Drug Discovery.

[2]  Bahram Hemmateenejad,et al.  Accurate prediction of the blood–brain partitioning of a large set of solutes using ab initio calculations and genetic neural network modeling , 2006, J. Comput. Chem..

[3]  György M. Keserü,et al.  High-throughput prediction of blood-brain partitioning: a thermodynamic approach. , 2001, Journal of chemical information and computer sciences.

[4]  Hxugo Kubiny Variable Selection in QSAR Studies. I. An Evolutionary Algorithm , 1994 .

[5]  B Testa,et al.  Predicting blood-brain barrier permeation from three-dimensional molecular structure. , 2000, Journal of medicinal chemistry.

[6]  Juan M. Luco,et al.  Prediction of the Brain-Blood Distribution of a Large Set of Drugs from Structurally Derived Descriptors Using Partial Least-Squares (PLS) Modeling , 1999, J. Chem. Inf. Comput. Sci..

[7]  Harpreet S. Chadha,et al.  Molecular Factors Influencing Drug Transfer across the Blood‐Brain Barrier , 1997, The Journal of pharmacy and pharmacology.

[8]  Weiliang Zhu,et al.  New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.

[9]  Irene Luque Ruiz,et al.  QSAR models based on isomorphic and nonisomorphic data fusion for predicting the blood brain barrier permeability , 2007, J. Comput. Chem..

[10]  Zhi-Wei Cao,et al.  Effect of Selection of Molecular Descriptors on the Prediction of Blood-Brain Barrier Penetrating and Nonpenetrating Agents by Statistical Learning Methods , 2005, J. Chem. Inf. Model..

[11]  M. Abraham,et al.  On the partition of ampholytes: application to blood-brain distribution. , 1997, Journal of pharmaceutical sciences.

[12]  Alexandre Varnek,et al.  Correlation of blood-brain penetration using structural descriptors. , 2006, Bioorganic & medicinal chemistry.

[13]  Douglas B. Kitchen,et al.  Computational models to predict blood–brain barrier permeation and CNS activity , 2003, J. Comput. Aided Mol. Des..

[14]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Ruifeng Liu,et al.  Development of Quantitative Structure-Property Relationship Models for Early ADME Evaluation in Drug Discovery. 2. Blood-Brain Barrier Penetration , 2001, J. Chem. Inf. Comput. Sci..

[16]  F. Lombardo,et al.  Computation of brain-blood partitioning of organic solutes via free energy calculations. , 1996, Journal of medicinal chemistry.

[17]  D. E. Clark,et al.  In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind” , 2005, Journal of Pharmacology and Experimental Therapeutics.

[18]  L. Molnár,et al.  Recent advances in the prediction of blood-brain partitioning from molecular structure. , 2003, Journal of pharmaceutical sciences.

[19]  Prabha Garg,et al.  In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model , 2006, J. Chem. Inf. Model..

[20]  Sean Ekins,et al.  Three‐Dimensional Quantitative Structure Activity Relationship for Cyp2d6 Substrates , 2002 .

[21]  Harpreet S. Chadha,et al.  Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.

[22]  Andreas Klamt,et al.  Prediction of Blood-Βrain Partitioning and Human Serum Albumin Binding Based on COSMO-RS σ-Moments , 2007, J. Chem. Inf. Model..

[23]  Lemont B. Kier,et al.  Modeling Blood-Brain Barrier Partitioning Using the Electrotopological State , 2002, J. Chem. Inf. Comput. Sci..

[24]  U Norinder,et al.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. , 1998, Journal of pharmaceutical sciences.

[25]  Marc Adenot,et al.  Blood-Brain Barrier Permeation Models: Discriminating between Potential CNS and Non-CNS Drugs Including P-Glycoprotein Substrates , 2004, J. Chem. Inf. Model..

[26]  Ajay,et al.  Designing libraries with CNS activity. , 1999, Journal of medicinal chemistry.

[27]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[28]  Stefan H. Unger,et al.  Model building in structure-activity relations. Reexamination of adrenergic blocking activity of .beta.-halo-.beta.-arylalkylamines , 1973 .

[29]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors , 2003, J. Chem. Inf. Comput. Sci..

[30]  Thomas Hofmann,et al.  Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms , 2002, J. Comput. Biol..

[31]  Yiannis N. Kaznessis,et al.  Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water , 2001, J. Comput. Aided Mol. Des..

[32]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[33]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[34]  Michael C. Hutter,et al.  Prediction of blood–brain barrier permeation using quantum chemically derived information , 2003, J. Comput. Aided Mol. Des..

[35]  Bernard De Baets,et al.  Feature subset selection for splice site prediction , 2002, ECCB.

[36]  M. Feher,et al.  A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.

[37]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[38]  Ramamurthi Narayanan,et al.  In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.

[39]  Shu-Shen Liu,et al.  VSMP: A Novel Variable Selection and Modeling Method Based on the Prediction , 2003, J. Chem. Inf. Comput. Sci..

[40]  Mark L. Lewis,et al.  Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation Schemes , 2007, J. Chem. Inf. Model..

[41]  Franco Lombardo,et al.  A recursive-partitioning model for blood–brain barrier permeation , 2005, J. Comput. Aided Mol. Des..

[42]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[43]  Igor V. Tetko,et al.  Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..

[44]  Neil L Allan,et al.  Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration. , 2007, Journal of molecular graphics & modelling.

[45]  Meihua Tu,et al.  Development of a computational approach to predict blood-brain barrier permeability. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[46]  W. L. Jorgensen The Many Roles of Computation in Drug Discovery , 2004, Science.

[47]  D. E. Clark In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.

[48]  H. Mewes,et al.  Can we estimate the accuracy of ADME-Tox predictions? , 2006, Drug discovery today.